Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia. The discovery, ...
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
MEMPHIS, Tenn. - Doctors call it an incredibly important but neglected disease. Memphis has some of the highest rates of sickle cell among babies in the entire nation. For this Sickle Cell Awareness ...
A Gurugram hospital study reveals significant success in curing Sickle Cell Disease among children through bone marrow ...
(Reuters) -U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths ...
Jayden Wilsey was the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease after federal approval in 2024.
On Wednesday, Pfizer Inc. (NYSE:PFE) said the company is voluntarily withdrawing all lots of Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
We present the case of a boy with sickle cell disease who developed fulminant fat embolism syndrome following parvovirus-B19 infection. After presenting with severe bone pain, his condition rapidly ...
One of the most vital treatments for sickle cell patients is regular blood transfusions; sometimes, it's needed multiple ...
Sickle cell disease can cause various eye-related complications, including retinopathy. If untreated, sickle cell retinopathy can cause permanent vision loss. Treatments include laser therapy and eye ...
When Amy Cohen, 29, finished the New York City Marathon, she broke ground as the first person with the illness to run the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback